In addition, STAT3 activation through phosphorylation in tumor cells has been demonstrated to negatively regulate the adaptive immune responses both by reducing pro-inflammatory cytokine production, and by production of soluble factors inhibiting DC maturation [22]. The gene discussed is STAT3; the disease is neoplasm.